Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Lisurida [Inn-Spanish]: Full Drug Profile
Medically reviewed by Dr. Otari Nergadze, Neurosurgeon | Updated: January 2026
Lisurida [Inn-Spanish] - General Information
An ergot derivative that acts as an agonist at dopamine D2 receptors (dopamine agonists). It may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors (serotonin agonists). [PubChem]
Pharmacology of Lisurida [Inn-Spanish]
Not Available
Additional information about Lisurida [Inn-Spanish]
- Lisurida [Inn-Spanish] Indication
For the management of Parkinson's Disease
- Mechanism Of Action
- Lisurida [Inn-Spanish] is an anti-Parkinson drug chemically related to the dopaminergic ergoline Parkinson's drugs. Lisurida [Inn-Spanish] binds to the 5-HT(1A) and 5-HT(2A/2C) receptors. It is also thought to bind to the dopamine receptor and to act as a dopamine agonist. Evidence has also emerged that Lisurida [Inn-Spanish] also binds to the Histamine H1 receptor. Lisurida [Inn-Spanish] is also used to lower prolactin and, in low doses, to prevent migraine attacks.
- Generic Name
- Lisuride
- Drug Category
- Antiparkinson Agents; Antidyskinetics
- Drug Type
- Small Molecule; Approved
- Other Brand Names containing Lisuride
- Lisurida [Inn-Spanish]; Lisuride Maleate; Lisuride [Inn]; Lisuridum [Inn-Latin]; Lysuride;
- Protein Binding
- about 15%
- Chemical Formula
- C20H26N4O
- Lisuride on Wikipedia
- https://en.wikipedia.org/wiki/Lisuride
- Organisms Affected
- Humans and other mammals